| Similar Articles |
|---|
 |
The Motley Fool
March 3, 2004
Alyce Lomax |
Biovail Gets Nailed... Again The Canadian drug maker's stock falls on downbeat guidance.   |
The Motley Fool
December 11, 2006
Brian Lawler |
Biovail Gives Investors the Cash Regardless of lower forward estimates, though, it's nice to see a mature biotech rewarding shareholders, and if Biovail can sustain its dividend over the long run, it will be by far the highest-yielding mid-cap pharma stock. |
The Motley Fool
March 25, 2008
Brian Orelli |
Biovail Hit by a Slow-Moving Truck Biovail finally settles with the SEC, more than four years after the agency started an investigation into the drugmaker. |
The Motley Fool
May 7, 2009
Brian Orelli |
Derailed and Built to Stay That Way Investors aren't happy with Biovail's plan to get back on track. |
The Motley Fool
October 29, 2007
Michael Goode |
Don't Sell a Short-Seller Short Trying to beat short-sellers can squeeze your wallet instead. |
The Motley Fool
November 21, 2007
Brian Orelli |
Depression Hits Biovail An FDA decision on Biovail's depression drug could be another six months away. |
